Depleted uranium (DU) is a weak radioactive heavy metal, and zinc (Zn) is an effective antidote to heavy metal poisoning. However, the effect of Zn on DU-induced cytotoxicity and apoptosis is not completely understood. The purpose of this study was to evaluate the effect of Zn on DU-induced cell apoptosis in human kidney cells (HK-2) and explore its molecular mechanism. Pre-treatment with Zn significantly inhibited DU-induced apoptosis. It reduced the formation of reactive oxygen species in the cells, increased the catalase (CAT) and glutathione (GSH) concentrations, suppressed the DU-induced soluble Fas receptor (sFasR) and soluble Fas ligand (sFasL) overexpression, suppressed the release of cytochrome c and apoptosis inhibitor factor (AIF) from mitochondria to cytoplasm, inhibited the activation of caspase-9, caspase-8 and caspase-3, and induced metallothionein (MT) expression. Furthermore, exogenous MT effectively inhibited DU-induced cell apoptosis. In conclusion, mitochondrial and FasR-mediated apoptosis pathways contribute to DU-induced apoptosis in HK-2 cells. Through independent mechanisms, such as indirect antioxidant effects, inhibition of the activation of caspase-9, caspase-8 and caspase-3, and induction of MT expression, Zn inhibits DU-induced apoptosis.Due to its high density and affordability, depleted uranium (DU) has been widely used in civilian and military activities. However, unregulated release of DU into the environment during its production and use could cause DU to enter the human body through the respiratory tract, gastrointestinal tract or skin, after which DU is distributed to bones, kidney, liver or reproductive organs, becoming a threat to human health [1].Depleted uranium has the dual effects of radioactive and heavy metal toxicities, particularly heavy metal toxicity [2,3]. The chemical toxicity of acute, high DU exposure especially targets the kidneys, causing severe renal proximal tubular necrosis, renal failure and, ultimately, death [4]. Kidney damage is caused when the uranium intake exceeds 2 mg/kg body-weight [5] or when kidney uranium deposition reaches 3 lg/g in a short time [6]. When human beings are exposed to high doses of DU in a short period of time, a decrease in glomerular filtration rate and increase in serum creatinine, urine protein and urine catalase (CAT) are observed [7,8]. Shim et al. [9] reported that on day 6 after one dose of uranyl nitrate intraperitoneal injection (0.5 mg/kg) in Sprague-Dawley rats, serum creatinine and blood urea nitrogen (BUN) were increased, and the creatinine clearance rate was decreased. Our preliminary study [4] demonstrated that one dose of uranyl acetate in rats via intraperitoneal injection (10 mg/kg, 4 days after injection) increased the uranium level in urine, liver, spleen and kidney. Moreover, higher serum creatinine, BUN and urinary N-acetyl-b-D glucosaminidase (NAG) were detected. A large number of casts, hyaline degeneration and vacuolization, and even shedding and necrosis of renal tubular epithelial cells, wer...